Stock Code

688016.SH

Recently, the first implantation of the Castor™ Branched Aortic Stent-Graft and Delivery System (Castor™ Branched Stent-Graft) and Hercules™ Thoracic Stent Graft with Low Profile Delivery System covered stent (Hercules™-LP Stent Graft) developed by Endovastec™, was completed at Tan Tock Seng Hospital by Professor Glenn Tan, Professor Pua Uei, Professor Lawrence Quek, and their team. This marks the first clinical use of Endovastec™’s products in Singapore.


The patient, diagnosed with a thoracic aortic aneurysm during a preoperative assessment, had a twisted and narrowed distal neck, a lengthy affected area, a large aneurysm with a maximum diameter exceeding 70 millimeters, and exhibited noticeable symptoms. This necessitated a Thoracic Endovascular Aortic Repair (TEVAR). After a comprehensive evaluation of the patient's imaging data and related measurements, the medical team decided to perform the surgery using a combination of Castor™ Branched Stent-Graft and Hercules™-LP Stent Graft, thereby establishing a more reliable, healthy anchoring zone when isolating the aneurysm.


The operation proceeded smoothly and postoperative angiography revealed precise positioning of the Castor™ Branched Stent-Graft, effectively isolating the aneurysm. The near-end triple small wave segment of the stent displayed excellent sealing without any endoleak or stent migration, and the blood flow in the supra-arch branch vessels remained unobstructed, resulting in a successful surgery.


Thus far, Castor™ Branched Stent-Graft has been introduced into clinical application in 16 countries worldwide, successfully treating over 18,000 patients, and Hercules®-LP Stent Graft has been introduced into clinical application in 18 countries globally, effectively treating more than 58,000 patients with aortic diseases.Endovastec™ will continue its unwavering commitment to advancing comprehensive medical solutions for aortic and peripheral vascular diseases, bringing more high-quality, innovative products to global markets.


About Castor™ Branched Stent-Graft and Hercules™-LP Stent Graft


Castor™ Branched Stent-Graft is designed for endovascular treatment of thoracic aortic dissection involving arch lesions and is the first approved branched aortic stent-graft for the market worldwide. Meanwhile, Hercules™-LP Stent Graft adopts a Low-Profile design, which can adapt to narrower and more tortuous access arteries. It is mainly suitable for endovascular treatment of thoracic aortic aneurysm or Stanford Type B thoracic aortic dissection.


百度 搜狗 360搜索 郭涛儿子石头晒自拍 【守望考据】雾子·白泽篇 美股暴跌致产品大幅回撤?但斌回应 股指基金规模站上1.7万亿元 银行代销靠什么抢市场? 直击南部战区海军海上补给训练

      <code id='a26ab'></code><style id='bcc1b'></style>
    • <acronym id='ab551'></acronym>
      <center id='642ca'><center id='f231f'><tfoot id='16220'></tfoot></center><abbr id='65f5c'><dir id='b81e9'><tfoot id='773bf'></tfoot><noframes id='12e79'>

    • <optgroup id='3c7fb'><strike id='dc6bd'><sup id='5bb65'></sup></strike><code id='916ee'></code></optgroup>
        1. <b id='a8d42'><label id='43094'><select id='6bbfc'><dt id='f6eb3'><span id='3bae3'></span></dt></select></label></b><u id='1e3ef'></u>
          <i id='c99a9'><strike id='71b01'><tt id='636ab'><pre id='12125'></pre></tt></strike></i>